Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation.

The importance of the sympathetic nervous system in essential hypertension has been recognized in 2 eras. The first was in early decades of the 20 ^th century, through to the 1960s. Here, the sympathetic nervous system was identified as a target for the treatment of hypertension, and an extensive range of antiadrenergic therapies were developed. Then, after a period of lapsed interest, in a second era from 1985 on, the development of precise measures of human sympathetic nerve firing and transmitter release allowed demonstration of the importance of neural mechanisms in the initiation and maintenance of the arterial blood pressure elevation in hypertension. This led to the development of a device treatment of hypertension, catheter-based renal denervation, which we will discuss.
Competing Interests: Disclosures M.D. Esler and J.W. Osborn have received consulting fees and travel and research support from Medtronic. M.P. Schlaich has received research support from Medtronic, Abbott, and Servier Australia. He serves on scientific advisory boards for Abbott, BI, Servier, Novartis, and Medtronic.